Implantable cardioverter defibrillator: decision-making on turning off in patients with end-stage heart failure

V. K. Lebedeva, D. S. Lebedev
2020 Russian Journal of Cardiology  
The use of implantable cardioverter defibrillators has become a common standard method of primary and secondary prevention of sudden cardiac death, prolonging the life of patients with cardiomyopathy. At the same time, with the disease and comorbidity progression, at the final stages of life, a difficult decision arises to turn off the device due to a shift in priorities from extending life to maintaining its quality. Heart failure patients eventually die due to the progression of the
more » ... disease, despite currently available advanced technologies. Whether certain lifesustaining treatment methods are still appropriate in the final stages of life is an important topic of discussion in this article. Palliation for patients with implantable cardioverter-defibrillators is a challenging issue for both patients and medical professionals. This article describes the different ways to turn off defibrillation devices based on patient status.
doi:10.15829/1560-4071-2020-3868 doaj:1d43641f760c411fb5e70015e602d8df fatcat:yqzabrdnzreevep4cit7zhtc4q